MetaCap

Zai Lab Limited ADR Company Profile

NASDAQ: ZLABHealth CareBiotechnology: Pharmaceutical PreparationsUSD

21.03-0.89 (-4.06%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Zai Lab at a glance

Zai Lab Limited ADR (NASDAQ: ZLAB) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Pudong, China. Zai Lab is led by Dr. Ying Du Ph.D. and employs about 1,784 people. The company's shares have traded publicly since 2017.

At a market capitalization of $2.63 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0001704292, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Zai Lab do?

Zai Lab Limited, a biopharmaceutical company, focuses on discovering, developing, and commercializing products that address medical conditions in the areas of oncology, immunology, neuroscience, and infectious diseases. Its commercial products include Zejula, an orally administered poly (ADP-ribose) polymerase 1/2 inhibitor for treating ovarian cancer; VYVGART, a human IgG1 antibody fragment for generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy; NUZYRA for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections; Optune for glioblastoma multiforme; Qinlock for gastrointestinal stromal tumors; Xacduro for treating hospital-acquired and ventilator-associated bacterial pneumonia caused by a cinetobacter baumannii-calcoaceticus complex; and Augtyro for the treatment of ROS proto-oncogene 1 and non-small cell lung cancer. The company has a strategic collaboration with Tesaro, Inc., NovoCure Ltd., Deciphera Pharmaceuticals, LLC, Paratek Bermuda Ltd., argent BV, Turning Point Therapeutics, Inc., Entasis Therapeutics Holdings Inc., Karuna Therapeutics, Inc., Pfizer Inc., Amgen Inc., and with Boehringer Ingelheim GmbH. The company was incorporated in 2013 and is based in Pudong, China.

Business description based on the company's public filings.

Company information

Legal name
Zai Lab Limited ADR
Ticker
NASDAQ: ZLAB
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Dr. Ying Du Ph.D.
Employees
1,784
Headquarters
Building B, Pudong, China
Phone
86 21 6163 2588
IPO year
2017
SEC CIK
0001704292
Latest annual report
10-K · Feb 26, 2026

Companies similar to Zai Lab

ZLAB peer companies
CompanyPrice% ChgMarket capCompare
XNCRXencor Inc.33.26-2.21%$2.50Bvs ZLAB
IDYAIDEAYA Biosciences Inc.25.56-2.33%$2.47Bvs ZLAB
SLSSELLAS Life Sciences Group Inc.13.66-8.08%$2.78Bvs ZLAB
MBXMBX Biosciences Inc.49.55-7.23%$2.46Bvs ZLAB
TLXTelix Pharmaceuticals Limited ADR8.37-3.90%$2.84Bvs ZLAB
PBHPrestige Consumer Healthcare Inc.49.63+0.06%$2.35Bvs ZLAB
DYNDyne Therapeutics Inc.15.50-3.31%$2.90Bvs ZLAB
HCMHUTCHMED (China) Limited ADR13.22-1.71%$2.30Bvs ZLAB

Related